Observational Prospective Study OPTIMA II - Follow-up

Clinical trial NCT02099565 · COMPLETED

Trial details

NCT number: NCT02099565
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)

Start date: 2014-05-01
Primary completion: 2015-04-01
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.